Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Sleep  COVID-19 treatment studies for Sleep  C19 studies: Sleep  Sleep   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
 
Sleep COVID-19 studies. Studies analyze sleep quality before infection, and use different definitions of sleep quality. Recent:
Jones.
Submit updates/corrections.
Sep 30
Covid Analysis (Preprint) (meta analysis) Sleep for COVID-19: real-time meta analysis of 8 studies
Statistically significant improvements are seen for mortality, hospitalization, recovery, and cases. 8 studies from 8 independent teams in 4 different countries show statistically significant improvements in isolation (7 for the most se..
Jul 21
Jones et al., Sleep Medicine, doi:10.1016/j.sleep.2022.05.369 Public health impact of poor sleep on COVID-19, influenza and upper respiratory infections
39% lower mortality [p=0.001], 32% lower hospitalization [p<0.0001], and 7% fewer cases [p=0.04]. FinnGen Mendelian randomization study showing higher risk of COVID-19 mortality, hospitalization, and infection with insomnia.
Apr 13
Paul et al., medRxiv, doi:10.1101/2022.04.12.22273792 (Preprint) Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: A longitudinal analysis of 1,811 UK adults
67% improved recovery [p<0.0001]. Retrospective 1,811 COVID-19 patients in the UK, showing lower risk of self-reported long COVID with good sleep quality in the month before infection.
Mar 22
Kim et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000228 COVID-19 illness in relation to sleep and burnout
17% fewer moderate/severe cases [p=0.03] and 11% fewer cases [p=0.003]. Retrospective 2,884 high-risk healthcare workers in France, Germany, Italy, Spain, UK, and the USA, showing shorter sleep duration associated with increased risk of COVID-19 cases and severity.
Nov 30
2021
Huang et al., Nature and Science of Sleep, doi:10.2147/NSS.S263488 Reduced Sleep in the Week Prior to Diagnosis of COVID-19 is Associated with the Severity of COVID-19
81% lower severe cases [p=0.02]. Retrospective 164 COVID-19 patients and 188 controls in China, showing the risk of severe cases associated with lack of sleep.
Sep 30
2021
Mohsin et al., Infection and Drug Resistance, doi:10.2147/IDR.S331470 Lifestyle and Comorbidity-Related Risk Factors of Severe and Critical COVID-19 Infection: A Comparative Study Among Survived COVID-19 Patients in Bangladesh
38% lower severe cases [p<0.0001]. Retrospective 1,500 COVID+ patients in Bangladesh, showing lower risk of severe cases with good sleep.
Jun 18
2021
Li et al., Sleep, doi:10.1093/sleep/zsab138 Poor sleep behavior burden and risk of COVID-19 mortality and hospitalization
43% lower mortality [p=0.02] and 36% lower hospitalization [p=0.008]. UK Biobank retrospective, 46,535 participants with sleep behavior assessed between 2006 and 2010, showing higher risk of hospitalization and mortality with poor sleep.
Jun 17
2021
Marcus et al., PLOS ONE, doi:10.1371/journal.pone.0253120 Predictors of incident viral symptoms ascertained in the era of COVID-19
16% fewer symptomatic cases [p=0.0007]. Prospective survey based study with 14,335 participants, showing risk of viral symptoms associated with shorter sleep duration.
Mar 30
2021
Holt et al., Thorax, doi:10.1136/thoraxjnl-2021-217487 Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)
12% fewer cases [p=0.5]. Prospective survey-based study with 15,227 people in the UK, showing reduced risk of COVID-19 cases with 8 hours sleep, with statistical significance when compared with ≥9 hours. NCT04330599. COVIDENCE UK.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit